Search

Your search keyword '"Le Cam-Duchez, V."' showing total 146 results

Search Constraints

Start Over You searched for: Author "Le Cam-Duchez, V." Remove constraint Author: "Le Cam-Duchez, V."
146 results on '"Le Cam-Duchez, V."'

Search Results

3. Cross‐reactivity of human anti‐FVIII antibodies to porcine rFVIII: French field study to validate the modified Nijmegen method.

17. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

20. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples

21. Intérêt d’une thromboprophylaxie adaptée au poids chez le patient obèse hospitalisé : étude comparative de 2 schémas posologiques d’énoxaparine (étude Itohenox)

24. Factor V Leiden Homozygous Genotype and Pregnancy Outcomes

31. Neurotransmetteurs et mort subite du nourrisson

34. Prothrombotic Inherited Abnormalities Other Than Factor V Leiden Mutation Do Not Play a Role in Venous Thrombosis in Inflammatory Bowel Disease.

37. Management of anti-vitamin K overdose, situations at hemorrhagic risk and hemorrhagic accidents among patients treated with anti-vitamin K in urban and hospital setting: Introduction,Prise en charge des surdosages en antivitamines K, des situations à risque hémorrahique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier: Introduction

38. Management of anti-vitamin K overdose, situations at hemorrhagic risk and hemorrhagic accidents among patients treated with anti-vitamin K in urban and hospital setting: Introduction | Prise en charge des surdosages en antivitamines K, des situations à risque hémorrahique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier: Introduction

40. Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.

41. Gene-Gene Interaction Between Factor- XI and ABO Genes in Cerebral Venous Thrombosis: The BEAST Study.

42. Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?

43. Endothelial Progenitor Cells in Autoimmune Disorders.

45. Stability over time of immature platelet fraction and comparison between EDTA and citrated whole blood samples.

46. C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.

47. Age of onset of cerebral venous thrombosis: the BEAST study.

48. Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease.

49. Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay.

50. Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease.

Catalog

Books, media, physical & digital resources